BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

32 related articles for article (PubMed ID: 2187024)

  • 1. Expression of PD-L1 in keratoacanthoma and different stages of progression in cutaneous squamous cell carcinoma.
    Gambichler T; Gnielka M; Rüddel I; Stockfleth E; Stücker M; Schmitz L
    Cancer Immunol Immunother; 2017 Sep; 66(9):1199-1204. PubMed ID: 28501937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple mechanisms generate HLA class I altered phenotypes in laryngeal carcinomas: high frequency of HLA haplotype loss associated with loss of heterozygosity in chromosome region 6p21.
    Maleno I; López-Nevot MA; Cabrera T; Salinero J; Garrido F
    Cancer Immunol Immunother; 2002 Sep; 51(7):389-96. PubMed ID: 12192539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Major histocompatibility complex class II in the tumor microenvironment: functions of nonprofessional antigen-presenting cells.
    Macy AM; Herrmann LM; Adams AC; Hastings KT
    Curr Opin Immunol; 2023 Aug; 83():102330. PubMed ID: 37130456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Immunogenetics of Non-melanoma Skin Cancer.
    Mushtaq S
    Adv Exp Med Biol; 2022; 1367():397-409. PubMed ID: 35286705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Profile of Basal Cell Carcinoma Mutations and Copy Number Alterations - Focus on Gene-Associated Noncoding Variants.
    Nawrocka PM; Galka-Marciniak P; Urbanek-Trzeciak MO; M-Thirusenthilarasan I; Szostak N; Philips A; Susok L; Sand M; Kozlowski P
    Front Oncol; 2021; 11():752579. PubMed ID: 34900699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Case Report: Combined Intra-Lesional IL-2 and Topical Imiquimod Safely and Effectively Clears Multi-Focal, High Grade Cutaneous Squamous Cell Cancer in a Combined Liver and Kidney Transplant Patient.
    Vidovic D; Simms GA; Pasternak S; Walsh M; Peltekian K; Stein J; Helyer LK; Giacomantonio CA
    Front Immunol; 2021; 12():678028. PubMed ID: 34122442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Keratinocyte Carcinomas: Current Concepts and Future Research Priorities.
    Nagarajan P; Asgari MM; Green AC; Guhan SM; Arron ST; Proby CM; Rollison DE; Harwood CA; Toland AE
    Clin Cancer Res; 2019 Apr; 25(8):2379-2391. PubMed ID: 30523023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cutaneous squamous cell cancer (cSCC) risk and the human leukocyte antigen (HLA) system.
    Yesantharao P; Wang W; Ioannidis NM; Demehri S; Whittemore AS; Asgari MM
    Hum Immunol; 2017 Apr; 78(4):327-335. PubMed ID: 28185865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA Antigen Profile Differences in Patients with SCC (Squamous Cell Carcinoma) In-Situ /Actinic Keratosis and Invasive SCC: Is There a Genetic Succeptibility for Invasive SCC Development?
    Atasoy M; Anadolu-Braise R; Pirim I; Dogan H; Ikbal M
    Eurasian J Med; 2009 Dec; 41(3):162-4. PubMed ID: 25610095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of MHC class I and class II antigens in primary breast carcinomas and synchronous nodal metastases.
    Maiorana A; Cesinaro AM; Fano RA; Collina G
    Clin Exp Metastasis; 1995 Jan; 13(1):43-8. PubMed ID: 7820955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential expression of HLA-DR, HLA-DP, HLA-DQ and associated invariant chain (Ii) in normal colorectal mucosa, adenoma and carcinoma.
    Degener T; Momburg F; Möller P
    Virchows Arch A Pathol Anat Histopathol; 1988; 412(4):315-22. PubMed ID: 3125670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Basal cell and squamous cell carcinomas. Clinico-histological features.
    Annessi G; Baliva G
    Ann Ist Super Sanita; 1996; 32(1):29-36. PubMed ID: 8804183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Actinic keratosis, Bowen's disease, keratoacanthoma and squamous cell carcinoma of the skin].
    Majores M; Bierhoff E
    Pathologe; 2015 Feb; 36(1):16-29. PubMed ID: 25663185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered expression of major histocompatibility complex (MHC) antigens by epidermal tumours.
    Markey AC; Churchill LJ; MacDonald DM
    J Cutan Pathol; 1990 Apr; 17(2):65-71. PubMed ID: 2187024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Keratinocyte expression of CD36 antigen in benign and malignant epidermal cell-derived tumours.
    Allen MH; Barker JN; MacDonald DM
    J Cutan Pathol; 1991 Jun; 18(3):198-203. PubMed ID: 1717527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential expression of major histocompatibility complex class II antigens on human keratinocytes.
    Niedecken H; Lutz G; Bauer R; Kreysel HW
    J Am Acad Dermatol; 1988 Dec; 19(6):1030-7. PubMed ID: 2462575
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.